Inducible expression of chimeric EWS/ETS proteins confers Ewing's family tumor-like phenotypes to human mesenchymal progenitor cells

Molecular and Cellular Biology

Volumn 28, Issue 7, 2008, Pages 2125-2137

  Miyagawa, Yoshitaka ^a   Okita, Hajime ^a   Nakaijima, Hideki ^a   Horiuchi, Yasuomi ^a   Sato, Ban ^a   Taguchi, Tomoko ^a   Toyoda, Masashi ^a   Katagiri, Yohko U ^a   Fujimoto, Junichiro ^a   Hata, Jun Ichi ^a   Umezawa, Akihiro ^a   Kiyokawa, Nobutaka ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; CD99 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MATRIGEL; MICROSOMAL AMINOPEPTIDASE; RNA BINDING PROTEIN EWS; STEM CELL FACTOR RECEPTOR; TETRACYCLINE; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR FLI 1;

ARTICLE; CELL CULTURE; CELL FUNCTION; CELL INVASION; CELL STRUCTURE; CONTROLLED STUDY; EWING SARCOMA; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOPHENOTYPING; MESENCHYMAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINDLE CELL; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD; CELL LINE, TRANSFORMED; CELL MOVEMENT; CELL SHAPE; COLLAGEN; DOXYCYCLINE; DRUG COMBINATIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, SYNTHETIC; HUMANS; IMMUNOPHENOTYPING; LAMININ; MESENCHYMAL STEM CELLS; NEOPLASTIC STEM CELLS; ONCOGENE PROTEINS, FUSION; PROTEOGLYCANS; PROTO-ONCOGENE PROTEIN C-FLI-1; RECOMBINANT FUSION PROTEINS; SARCOMA, EWING'S; TETRACYCLINE; TRANSCRIPTION FACTORS;

EID: 41149089612     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00740-07     Document Type: Article

References (53)

1. Akagi, T. 2004. Oncogenic transformation of human cells: shortcomings of rodent model systems. Trends Mol. Med. 10:542-548.
2. Ambros, I. M., P. F. Ambros, S. Strehl, H. Kovar, H. Gadner, and M. Salzer-Kuntschik. 1991. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 67:1886-1893.
3. Arvand, A., and C. T. Denny. 2001. Biology of EWS/ETS fusions in Ewing's family tumors. Oncogene 20:5747-5754.
4. Bertani, N., P. Malatesta, G. Volpi, P. Sonego, and R. Perris. 2005. Neurogenic potential of human mesenchymal stem cells revisited: analysis by immunostaining, time-lapse video and microarray. J. Cell Sci. 118:3925-3936.
5. Bloom, E. T. 1972. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture. Cancer Res. 32:960-967.
6. Castillero-Trejo, Y., S. Eliazer, L. Xiang, J. A. Richardson, and R. L. Ilaria, Jr. 2005. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells results in EWS/FLI-1-dependent, Ewing sarcoma-like tumors. Cancer Res. 65:8698-8705.
7. Colter, D. C., I. Sekiya, and D. J. Prockop. 2001. Identification of a sub-population of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc. Natl. Acad. Sci. USA 98:7841-7845.
8. Conget, P. A., and J. J. Minguell. 1999. Phenotypical Eind functional properties of human bone marrow mesenchymal progenitor cells. J. Cell. Physiol. 181:67-73.
9. Davis, S., and P. S. Meltzer. 2006. Ewing's sarcoma: general insights from a rare model. Cancer Cell 9:331-332.
10. Deneen, B., and C. T. Denny. 2001. Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation. Oncogene 20:6731-6741.
11. Deneen, B., S. M. Welford, T. Ho, F. Hernandez, I. Kurland, and C. T. Denny. 2003. PIM3 proto-oncogene kinase is a common transcriptional target of divergent EWS/ETS oncoproteins. Mol. Cell. Biol. 23:3897-3908.
12. Eliazer, S., J. Spencer, D. Ye, E. Olson, and R. L. Ilaria, Jr. 2003. Alteration of mesodermal cell differentiation by EWS/FLI-1, the oncogene implicated in Ewing's sarcoma. Mol. Cell. Biol. 23:482-492.
13. Fujii, Y., Y. Nakagawa, T. Hongo, Y. Igarashi, Y. Naito, and M. Maeda. 1989. Cell line of small round cell tumor originating in the chest wall: W-ES. Hum. Cell 2:190-191. (In Japanese.)
14. Fukuma, M., H. Okita, J. Hata, and A. Umezawa. 2003. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma. Oncogene 22:1-9.
15. Gilbert, F., G. Balaban, P. Moorhead, D. Bianchi, and H. Schlesinger. 1982. Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines. Cancer Genet. Cytogenet. 7:33-42.
16. Girish, V., and A. Vijayalakshmi. 2004. Affordable image analysis using NIH Image/ImageJ. Indian J. Cancer 41:47.
17. Gonzalez, I., E. J. Andreu, A. Panizo, S. Inoges, A. Fontalba, J. L. Fernandez-Luna, M. Gaboli, L. Sierrasesumaga, S. Martin-Algarra, J. Pardo, F. Prosper, and E. de Alava. 2004. Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis. Clin. Cancer Res. 10:751-761.
18. Hansen, M. B., S. E. Nielsen, and K. Berg. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119:203-210.
19. Hara, S., E. Ishii, S. Tanaka, J. Yokoyama, K. Katsumata, J. Fujimoto, and J. Hata. 1989. A monoclonal antibody specifically reactive with Ewing's sarcoma. Br J. Cancer 60:875-879.
20. Hatori, M., H. Doi, M. Watanabe, H. Sasano, M. Hosaka, S. Kotajima, F. Urano, J. Hata, and S. Kokubun. 2006. Establishment and characterization of a clonal human extraskeletal Ewing's sarcoma cell line, EES1. Tohoku J. Exp. Med. 210:221-230.
21. Homma, C., Y. Kaneko, K. Sekine, S. Hara, J. Hata, and M. Sakurai. 1989. Establishment and characterization of a small round cell sarcoma cell line, SCCH-196, with t(11;22)(q24;q12). Jpn. J. Cancer Res. 80:861-865.
22. Hubert, R. S., I. Vivanco, E. Chen, S. Rastegar, K. Leong, S. C. Mitchell, R. Madraswala, Y. Zhou, J. Kuo, A. B. Raitano, A. Jakobovits, D. C. Saffran, and D. E. Afar. 1999. STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc. Natl. Acad. Sci. USA 96:14523-14528.
23. Hu-Lieskovan, S., J. Zhang, L. Wu, H. Shimada, D. E. Schofield, and T. J. Triche. 2005. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors. Cancer Res. 65:4633-4644.
24. Im, Y. H., H. T. Kim, C. Lee, D. Poulin, S. Welford, P. H. Sorensen, C. T. Denny, and S. J. Kim. 2000. EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene. Cancer Res. 60:1536-1540.
25. Jones, E. A., S. E. Kinsey, A. English, R. A. Jones, L. Straszynski, D. M. Meredith, A. F. Markham, A. Jack, P. Emery, and D. McGonagle. 2002. Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arthritis Rheum. 46:3349-3360.
26. Khoury, J. D. 2005. Ewing sarcoma family of tumors. Adv. Anat. Pathol. 12:212-220.
27. Kiyokawa, N., Y. Kokai, K. Ishimoto, H. Fujita, J. Fujimoto, and J. I. Hata. 1990. Characterization of the common acute lymphoblastic leukaemia antigen (CD10) as an activation molecule on mature human B cells. Clin. Exp. Immunol. 79:322-327.
28. Konemann, S., T. Bolling, A. Schuck, J. Malath, A. Kolkmeyer, K. Horn, D. Riesenbeck, S. Hesselmann, R. Diallo, J. Vormoor, and N. A. Willich. 2003. Effect of radiation on Ewing tumour subpopulations characterized on a single-cell level: intracellular cytokine, immunophenotypic, DNA and apoptotic profile. Int. J. Radiat. Biol. 79:181-192.
29. Kovar, H., and A. Bernard. 2006. CD99-positive "Ewing's sarcoma" from mouse bone marrow-derived mesenchymal progenitor cells? Cancer Res. 66:9786.
30. Kovar, H., M. Dworzak, S. Strehl, E. Schnell, I. M. Ambros, P. F. Ambros, and H. Gadner. 1990. Overexpression of the pscudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Oncogene 5:1067-1070.
31. Lessnick, S. L., C. S. Dacwag, and T. R. Golub. 2002. The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell 1:393-401.
32. Lin, P. P., R. I. Brody, A. C. Hamelin, J. E. Bradner, J. H. Healey, and M. Ladanyi. 1999. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma. Cancer Res. 59:1428-1432.
33. Lipinski, M., K. Braham, I. Philip, J. Wiels, T. Philip, C. Goridis, G. M. Lenoir, and T. Tursz. 1987. Neuroectoderm-associated antigens on Ewing's sarcoma cell lines. Cancer Res. 47:183-187.
34. Lochter, A., A. Srebrow, C. J. Sympson, N. Terracio, Z. Werb, and M. J. Bissell. 1997. Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties. J. Biol. Chem. 272:5007-5015.
35. May, W. A., A. Arvand, A. D. Thompson, B. S. Braun, M. Wright, and C. T. Denny. 1997. EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic. Nat. Genet. 17:495-497.
36. May, W. A., S. L. Lessnick, B. S. Braun, M. Klemsz, B. C. Lewis, L. B. Lunsford, R. Hromas, and C. T. Denny. 1993. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol. Cell. Biol. 13:7393-7398.
37. Miyagawa, Y., J. M. Lee, T. Maeda, K. Koga, Y. Kawaguchi, and T. Kusakabe. 2005. Differential expression of a Bombyx mori AHA1 homologue during spermatogenesis. Insect Mol. Biol. 14:245-253.
38. Mori, T., T. Kiyono, H. Imabayashi, Y. Takeda, K. Tsuchiya, S. Miyoshi, H. Makino, K. Matsumoto, H. Saito, S. Ogawa, M. Sakamoto, J. Hata, and A. Umezawa. 2005. Combination of hTERT and bmi-1, E6, or E7 induces prolongation of the life span of bone marrow stromal cells from an elderly donor without affecting their neurogenic potential. Mol. Cell. Biol. 25:5183-5195.
39. Nishimori, H., Y. Sasaki, K. Yoshida, H. Irifune, H. Zembutsu, T. Tanaka, T. Aoyama, T. Hosaka, S. Kawaguchi, T. Wada, J. Hata, J. Toguchida, Y. Nakamura, and T. Tokino. 2002. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors. Oncogene 21:8302-8309.
40. Ogose, A., T. Motoyama, T. Hotta, and H. Watanabe. 1995. In vitro differentiation and proliferation in a newly established human rhabdomyosarcoma cell line. Virchows Arch. 426:385-391.
41. Prieur, A., F. Tirode, P. Cohen, and O. Delattre. 2004. EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol. Cell. Biol. 24:7275-7283.
42. Quirici, N., D. Soligo, P. Bossolasco, F. Servida, C. Lumini, and G. L. Deliliers. 2002. Isolation of bone marrow mesenchymal stem cells by antinerve growth factor receptor antibodies. Exp. Hematol. 30:783-791.
43. Reyes, M., T. Lund, T. Lenvik, D. Aguiar, L. Koodie, and C. M. Verfaillie. 2001. Purification and ex vivo expansion of postnatal human marrow meso-dermal progenitor cells. Blood 98:2615-2625.
44. Reyes, M., and C. M. Verfaillie. 2001. Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann. N. Y. Acad. Sci. 938:231-235.
45. Riggi, N., L. Cironi, P. Provero, M. L. Suva, K. Kaloulis, C. Garcia-Echeverria, F. Hoffmann, A. Trumpp, and I. Stamenkovic. 2005. Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res. 65:11459-11468.
46. Riggi, N., M. L. Suva, and I. Stamenkovic. 2006. Ewing's sarcoma-like tumors originate from EWS-FLI-1-expressing mesenchymal progenitor cells. Cancer Res. 66:9786.
47. Sekiguchi, M., T. Oota, K. Sakakibara, N. Inui, and G. Fujii. 1979. Establishment and characterization of a human neuroblastoma cell line in tissue culture. Jpn. J. Exp. Med. 49:67-83.
48. Smith, R., L. A. Owen, D. J. Trem, J. S. Wong, J. S. Whangbo, T. R. Golub, and S. L. Lessnick. 2006. Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. Cancer Cell 9:405-416.
49. Staege, M. S., C. Hutter, I. Neumann, S. Foja, U. E. Hattenhorst, G. Hansen, D. Afar, and S. E. Burdach. 2004. DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Cancer Res. 64:8213-8221.
50. Takeda, Y., T. Mori, H. Imabayashi, T. Kiyono, S. Gojo, S. Miyoshi, N. Hida, M. Ita, K. Segawa, S. Ogawa, M. Sakamoto, S. Nakamura, and A. Umezawa. 2004. Can the life span of human marrow stromal cells be prolonged by bmi-1, E6, E7, and/or telomerase without affecting cardiomyogenic differentiation? J. Gene Med. 6:833-845.
51. Tondreau, T., N. Meuleman, A. Delforge, M. Dejeneffe, R. Leroy, M. Massy, C. Mortier, D. Bron, and L. Lagneaux. 2005. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 23:1105-1112.
52. Torchia, E. C., S. Jaishankar, and S. J. Baker. 2003. Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells. Cancer Res. 63:3464-3468.
53. Woodbury, D., E. J. Schwarz, D. J. Prockop, and I. B. Black. 2000. Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 61:364-370.